Raynaud's phenomenon triggered by the vasopressin V2 receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome.

Roca Oporto, F JRocha, Jose L2023-05-032023-05-032021-12-092048-8505http://hdl.handle.net/10668/19739enAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/Raynaud's phenomenon triggered by the vasopressin V2 receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome.research article35371438open access10.1093/ckj/sfab260PMC8967664https://academic.oup.com/ckj/article-pdf/15/4/827/43057982/sfab260.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967664/pdf